NITROFURANTOIN 50 MG
NITROFURANTOIN : 50 MG · DIN 00319511 · AA PHARMA INC
Health Canada status: MARKETED
What is NITROFURANTOIN?
NITROFURANTOIN 50 MG contains NITROFURANTOIN : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 00319511, held by AA PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 29-Nov-2010. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00319511 |
|---|---|
| Brand name | NITROFURANTOIN |
| Generic / active ingredient | NITROFURANTOIN : 50 MG |
| Manufacturer | AA PHARMA INC |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J01XE01 NITROFURANTOIN |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 29-Nov-2010 |
| Original market date | 1964-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code J01XE01 NITROFURANTOIN. 9 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AURO-NITROFURANTOIN BID | 100 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02466392 |
| JAMP NITROFURANTOIN | 100 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | DIN 02495511 |
| JAMP NITROFURANTOIN | 50 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | DIN 02495503 |
| JAMP NITROFURANTOIN BID | 100 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | DIN 02544954 |
| NITROFURANTOIN | 100 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00312738 |
| PMS-NITROFURANTOIN BID | 100 MG | CAPSULE | PHARMASCIENCE INC | MARKETED | DIN 02455676 |
| TEVA-NITROFURANTOIN | 100 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED | DIN 02231016 |
| TEVA-NITROFURANTOIN | 50 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED | DIN 02231015 |
| MACROBID | 100 MG | CAPSULE | ALLERGAN INC | CANCELLED POST MARKET | DIN 02063662 |
| MACRODANTIN | 25 MG | CAPSULE | ALZA CORPORATION | CANCELLED POST MARKET | DIN 01997599 |
Who else supplies NITROFURANTOIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. NITROFURANTOIN appears in 46 registered pack listings across 10 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.